November 2016 edition
Our November edition is available to read now. The issue features companies and insight articles focused on nucleic-acid-based drugs, CNS and recent M&A activity in the pharma and biotech industry.
Read the newly released November edition of BioPharma Dealmakers.
Browse through the companies looking for partnerships in CNS and nucleic-acid-based drugs.
Aligning to these company profiles are our November in-depth feature articles that explore focus on the dealmaking activity within CNS, Pharma M&As and Nucleic-acid-based drugs.
No comments yet.